{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:04:44Z","timestamp":1789992284168,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.neuroscience.2016.04.046","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T13:43:40Z","timestamp":1462455820000},"page":"165-183","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies"],"prefix":"10.1016","volume":"328","author":[{"given":"Silke","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Warfvinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Dovlatyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Edvinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2016.04.046_b0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ar.1090940210","article-title":"Estimation of nuclear population from microtome sections","volume":"94","author":"Abercrombie","year":"1946","journal-title":"Anat Rec"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0010","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrn3057","article-title":"Diencephalic and brainstem mechanisms in migraine","volume":"12","author":"Akerman","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tips.2011.05.007","article-title":"Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development","volume":"32","author":"Archbold","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0020","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1474-4422(15)00249-5","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0030","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/bcp.12591","article-title":"Therapeutic antibodies against CGRP or its receptor","volume":"79","author":"Bigal","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0035","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1526-4610.2009.01523.x","article-title":"Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan","volume":"49","author":"Cady","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1744-8069-7-94","article-title":"Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization","volume":"7","author":"Cady","year":"2011","journal-title":"Mol Pain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1744-8069-5-43","article-title":"Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology","volume":"5","author":"Capuano","year":"2009","journal-title":"Mol Pain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0050","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1212\/WNL.0b013e3181b87942","article-title":"Randomized, controlled trial of telcagepant for the acute treatment of migraine","volume":"73","author":"Connor","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cne.20669","article-title":"Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat","volume":"490","author":"Cottrell","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0060","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1039\/C4AY00447G","article-title":"Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis","volume":"6","author":"Creamer","year":"2014","journal-title":"Anal Methods"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2011.11.058","article-title":"Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion \u2013 interaction with the sensory system","volume":"1435","author":"Csati","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.05.013","article-title":"Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1\u03b2 pro-inflammatory effects","volume":"237","author":"De Corato","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0333102410388435","article-title":"BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study","volume":"31","author":"Diener","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","article-title":"Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd3991","article-title":"Antibody drugs set to revive flagging migraine target","volume":"12","author":"Dolgin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/bjp.2008.346","article-title":"CGRP blockers in migraine therapy: where do they act?","volume":"155","author":"Edvinsson","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bcp.12618","article-title":"CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment","volume":"80","author":"Edvinsson","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/head.12656","article-title":"The journey to establish CGRP as a migraine target: a retrospective view","volume":"55","author":"Edvinsson","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","article-title":"Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium derived relaxing factor in the cat","volume":"58","author":"Edvinsson","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(01)01532-1","article-title":"Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells","volume":"434","author":"Edvinsson","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0120","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/0333102410362122","article-title":"Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries","volume":"30","author":"Edvinsson","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mcn.2010.10.005","article-title":"Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat","volume":"46","author":"Edvinsson","year":"2011","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0130","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1756285610388343","article-title":"Possible sites of action of the new calcitonin gene-related peptide receptor antagonists","volume":"3","author":"Eftekhari","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2202-12-112","article-title":"Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level","volume":"12","author":"Eftekhari","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","article-title":"Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion","volume":"169","author":"Eftekhari","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12311-013-0509-4","article-title":"Localization of CGRP receptor components, CGRP, and receptor binding sites in human and rhesus cerebellar cortex","volume":"12","author":"Eftekhari","year":"2013","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0150","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J Pain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cne.23828","article-title":"Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: a detailed study using in situ hybridization, immunofluorescence, and autoradiography","volume":"524","author":"Eftekhari","year":"2016","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0165","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1468-29821995.1505384.x","article-title":"Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally","volume":"15","author":"Gallai","year":"1995","journal-title":"Cephalalgia"},{"issue":"Suppl 17","key":"10.1016\/j.neuroscience.2016.04.046_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0333102497017S1704","article-title":"Is a central action of acute antimigraine drugs essential?","volume":"17","author":"Goadsby","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.1985.sp015573","article-title":"Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones","volume":"359","author":"Harper","year":"1985","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0190","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/978-1-4939-2694-7_47","article-title":"Protein detection by Simple Western\u2122 analysis","volume":"1312","author":"Harris","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0333102411398399","article-title":"Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine","volume":"31","author":"Hewitt","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0200","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","article-title":"Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial","volume":"372","author":"Ho","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/0333102410370878","article-title":"Randomized, controlled trial of telcagepant over four migraine attacks","volume":"30","author":"Ho","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1124\/jpet.113.206458","article-title":"In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232","volume":"347","author":"Hostetler","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(01)00760-9","article-title":"Characterization of CGRP(1) receptors in the guinea pig basilar artery","volume":"414","author":"Jansen-Olesen","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2003.09.021","article-title":"In-depth characterization of CGRP receptors in human intracranial arteries","volume":"481","author":"Jansen-Olesen","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","article-title":"NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release","volume":"106","author":"Juhasz","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/WCO.0000000000000191","article-title":"Calcitonin gene-related peptide and migraine","volume":"28","author":"Karsan","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0235","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.123.4.1548","article-title":"A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines","volume":"123","author":"Kearney","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0245","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","article-title":"Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution","volume":"507","author":"Lennerz","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0255","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1468-2982.2008.01829.x","article-title":"Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats","volume":"29","author":"Liu","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s10194-015-0575-8","article-title":"Experimental inflammation following dural application of complete Freund\u2019s adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage","volume":"16","author":"Lundblad","year":"2015","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0265","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/brain\/awt320","article-title":"Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks","volume":"137","author":"Maniyar","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0270","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2007.05.036","article-title":"Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors","volume":"148","author":"Marvizon","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","article-title":"RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor","volume":"393","author":"McLatchie","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0280","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0028-3908(02)00008-4","article-title":"Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment","volume":"42","author":"Moreno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0285","doi-asserted-by":"crossref","first-page":"v","DOI":"10.1038\/nmeth.f.353","article-title":"The Simple Western\u2122: a gel-free, blot-free, hands-free Western blotting reinvention","volume":"8","author":"Nguyen","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0290","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0295","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","article-title":"Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature","volume":"22","author":"Oliver","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0300","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-2982.1997.1703166.x","article-title":"Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide","volume":"17","author":"Ottosson","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0305","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1017\/S1462399411002067","article-title":"Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation","volume":"13","author":"Raddant","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0310","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1523\/JNEUROSCI.1727-09.2009","article-title":"Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine","volume":"29","author":"Recober","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2009.07.009","article-title":"Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP","volume":"58","author":"Recober","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.115.227793","article-title":"Pharmacologic characterization of AMG 334, a potent and selective human monoclonal antibody against the calcitonin gene-related peptide receptor","volume":"356","author":"Shi","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0325","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1093\/brain\/awq224","article-title":"Modulation of nociceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus","volume":"133","author":"Summ","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(16)00019-3","article-title":"Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial","author":"Sun","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11916-015-0533-9","article-title":"Update on the pharmacological treatment of chronic migraine","volume":"20","author":"Sun-Edelstein","year":"2016","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0340","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.str.2010.05.014","article-title":"Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism","volume":"18","author":"ter Haar","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0345","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0333102411398403","article-title":"Possible site of action of CGRP antagonists in migraine","volume":"31","author":"Tfelt-Hansen","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0350","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1526-4610.2007.00854.x","article-title":"Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology","volume":"47","author":"Thalakoti","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0355","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.64.10_suppl_2.S9","article-title":"Migraine as an inflammatory disorder","volume":"64","author":"Waeber","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0360","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0306-4522(99)00088-3","article-title":"Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord","volume":"92","author":"Ye","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0365","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/002215540104900301","article-title":"A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural level","volume":"49","author":"Yi","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.neuroscience.2016.04.046_b0370","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","article-title":"Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion","volume":"27","author":"Zhang","year":"2007","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216301312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452216301312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T22:40:07Z","timestamp":1692312007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452216301312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":74,"alternative-id":["S0306452216301312"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2016.04.046","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}